Automated preparation of chemotherapy: Quality improvement and economic sustainability

Carla Masini, Oriana Nanni, Sara Antaridi, Davide Gallegati, Mattia Marri, Demis Paolucci, Martina Minguzzi, Mattia Altini

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose. The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. Methods. This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Participating pharmacists and technicians completed a survey rating each preparation method in terms of performance, operator satisfaction, technology, and safety. Results. Of the 2500 i.v. antineoplastic preparations made in the pharmacy during the four-week study period, 681 were analyzed (348 using the automated procedure and 333 manually). Of these, 17 varied by more than 5% of the prescribed dose, and 1 varied by over 10%. Accuracy, calculated in terms of average percent relative error, was the highest and lowest during manual preparation. The preparation time for individual drugs was always higher when prepared using the automated procedure. A lower mean variable unit cost was observed for preparations made using the automated procedure. Questionnaire results revealed that operators preferred the automated procedure over the manual procedure. Conclusion. Both the automated and manual procedures for preparing antineoplastic preparations proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality maintenance standards and risk lowering.

Original languageEnglish
Pages (from-to)579-585
Number of pages7
JournalAmerican Journal of Health-System Pharmacy
Volume71
Issue number7
DOIs
Publication statusPublished - Apr 1 2014

Fingerprint

Quality Improvement
Economics
Drug Therapy
Antineoplastic Agents
oxaliplatin
irinotecan
gemcitabine
Costs and Cost Analysis
Etoposide
Pharmacists
Fluorouracil
Pharmaceutical Preparations
Cyclophosphamide
Prescriptions
Maintenance
Technology
Safety

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Medicine(all)

Cite this

Automated preparation of chemotherapy : Quality improvement and economic sustainability. / Masini, Carla; Nanni, Oriana; Antaridi, Sara; Gallegati, Davide; Marri, Mattia; Paolucci, Demis; Minguzzi, Martina; Altini, Mattia.

In: American Journal of Health-System Pharmacy, Vol. 71, No. 7, 01.04.2014, p. 579-585.

Research output: Contribution to journalArticle

Masini, Carla ; Nanni, Oriana ; Antaridi, Sara ; Gallegati, Davide ; Marri, Mattia ; Paolucci, Demis ; Minguzzi, Martina ; Altini, Mattia. / Automated preparation of chemotherapy : Quality improvement and economic sustainability. In: American Journal of Health-System Pharmacy. 2014 ; Vol. 71, No. 7. pp. 579-585.
@article{248ccbb5e32d4a3bac1c26205d24330e,
title = "Automated preparation of chemotherapy: Quality improvement and economic sustainability",
abstract = "Purpose. The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. Methods. This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Participating pharmacists and technicians completed a survey rating each preparation method in terms of performance, operator satisfaction, technology, and safety. Results. Of the 2500 i.v. antineoplastic preparations made in the pharmacy during the four-week study period, 681 were analyzed (348 using the automated procedure and 333 manually). Of these, 17 varied by more than 5{\%} of the prescribed dose, and 1 varied by over 10{\%}. Accuracy, calculated in terms of average percent relative error, was the highest and lowest during manual preparation. The preparation time for individual drugs was always higher when prepared using the automated procedure. A lower mean variable unit cost was observed for preparations made using the automated procedure. Questionnaire results revealed that operators preferred the automated procedure over the manual procedure. Conclusion. Both the automated and manual procedures for preparing antineoplastic preparations proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality maintenance standards and risk lowering.",
author = "Carla Masini and Oriana Nanni and Sara Antaridi and Davide Gallegati and Mattia Marri and Demis Paolucci and Martina Minguzzi and Mattia Altini",
year = "2014",
month = "4",
day = "1",
doi = "10.2146/ajhp130489",
language = "English",
volume = "71",
pages = "579--585",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "7",

}

TY - JOUR

T1 - Automated preparation of chemotherapy

T2 - Quality improvement and economic sustainability

AU - Masini, Carla

AU - Nanni, Oriana

AU - Antaridi, Sara

AU - Gallegati, Davide

AU - Marri, Mattia

AU - Paolucci, Demis

AU - Minguzzi, Martina

AU - Altini, Mattia

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Purpose. The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. Methods. This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Participating pharmacists and technicians completed a survey rating each preparation method in terms of performance, operator satisfaction, technology, and safety. Results. Of the 2500 i.v. antineoplastic preparations made in the pharmacy during the four-week study period, 681 were analyzed (348 using the automated procedure and 333 manually). Of these, 17 varied by more than 5% of the prescribed dose, and 1 varied by over 10%. Accuracy, calculated in terms of average percent relative error, was the highest and lowest during manual preparation. The preparation time for individual drugs was always higher when prepared using the automated procedure. A lower mean variable unit cost was observed for preparations made using the automated procedure. Questionnaire results revealed that operators preferred the automated procedure over the manual procedure. Conclusion. Both the automated and manual procedures for preparing antineoplastic preparations proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality maintenance standards and risk lowering.

AB - Purpose. The quality and economic implications of manual versus automated preparation of antineoplastic drugs were compared. Methods. This four-week study evaluated 10 routinely used antineoplastic drugs (fluorouracil, cyclophosphamide, gemcitabine, trastuzumab, bevacizumab, oxaliplatin, cisplatin, paclitaxel, irinotecan, and etoposide) prepared by manual and automated procedures. The accuracy of the dose of the active ingredient was calculated in terms of percent relative error for the difference between the nominal value indicated on the prescription and the actual value of the drug in the finished product. A comparative economic analysis of the manual and automated preparation procedures was performed by calculating the mean unit cost for each preparation at different production levels. Participating pharmacists and technicians completed a survey rating each preparation method in terms of performance, operator satisfaction, technology, and safety. Results. Of the 2500 i.v. antineoplastic preparations made in the pharmacy during the four-week study period, 681 were analyzed (348 using the automated procedure and 333 manually). Of these, 17 varied by more than 5% of the prescribed dose, and 1 varied by over 10%. Accuracy, calculated in terms of average percent relative error, was the highest and lowest during manual preparation. The preparation time for individual drugs was always higher when prepared using the automated procedure. A lower mean variable unit cost was observed for preparations made using the automated procedure. Questionnaire results revealed that operators preferred the automated procedure over the manual procedure. Conclusion. Both the automated and manual procedures for preparing antineoplastic preparations proved to be accurate and precise. The automated procedure resulted in substantial advantages in terms of quality maintenance standards and risk lowering.

UR - http://www.scopus.com/inward/record.url?scp=84907203940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907203940&partnerID=8YFLogxK

U2 - 10.2146/ajhp130489

DO - 10.2146/ajhp130489

M3 - Article

C2 - 24644118

AN - SCOPUS:84907203940

VL - 71

SP - 579

EP - 585

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 7

ER -